Initial Statement of Ownership

Dyne Therapeutics, Inc. Filed 2024-09-03 Acc 0000950170-24-103032

Documents 1

2024-09-04 4 Director sold 31,300 shares at an average $45.59 ($1,427,063)
2024-09-03 8-K Executive or director change · Regulation FD disclosure · Other events
2024-09-03 4 Chief Medical Officer acquired 47,500 shares (grant or award)
2024-09-03 3 Initial Statement of Ownership
2024-09-03 4 Chief Commercial Officer acquired 58,400 shares (grant or award)
2024-09-03 3 Initial Statement of Ownership
2024-03-27 3 Initial Statement of Ownership

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslF345X02/ownership.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…